SCHEMBL23212925

SCHEMBL23212925

OCCC(CCO)c1cc(F)ccc1OCc1ccccc1.[AlH3].[LiH]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 1/20 0.43
SLC6A5 Q9Y345 1/20 0.43
MRGPRX4 Q96LA9 3/20 0.41
LRRK2 Q5S007 2/20 0.40
PTGER1 P34995 2/20 0.39
LIPE Q05469 1/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.39
CFD P00746 1/20 0.39
TPSB2 P20231 1/20 0.39
MAPK1 P28482 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
NPC1 O15118 1/20 0.39
PPIA P62937 1/20 0.38
USP28 Q96RU2 1/20 0.38
USP25 Q9UHP3 1/20 0.38
FFAR1 O14842 1/20 0.38
FFAR4 Q5NUL3 1/20 0.38
AKR1C3 P42330 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29619704 0.97 SLC6A9 (0.45) SLC6A9SLC6A5MRGPRX4LRRK2PTGER1
SCHEMBL23210176 0.97 SLC6A9 (0.45) SLC6A9SLC6A5MRGPRX4LRRK2PTGER1
SCHEMBL23209843 0.86 SLC6A9 (0.42) SLC6A9SLC6A5MRGPRX4PTGER1LIPE
SCHEMBL29619701 0.86 SLC6A9 (0.42) SLC6A9SLC6A5MRGPRX4PTGER1LIPE
SCHEMBL23212914 0.86 SGMS2 (0.46) LIPEL3MBTL1LMNAMAPTCFD
SCHEMBL29619700 0.83 SGMS2 (0.48) LIPEL3MBTL1LMNAMAPTMAPK1
SCHEMBL23210255 0.83 SGMS2 (0.48) LIPEL3MBTL1LMNAMAPTMAPK1
SCHEMBL29619690 0.82 MRGPRX4 (0.41) MRGPRX4PTGER1LIPEL3MBTL1LMNA
SCHEMBL23295193 0.82 MRGPRX4 (0.41) MRGPRX4PTGER1LIPEL3MBTL1LMNA
SCHEMBL31357719 0.81 SLC6A9 (0.43) SLC6A9SLC6A5MRGPRX4LRRK2PTGER1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4041389-A1 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS Novartis AG (CH) 2022-08-17 EP disclosed
EP-4041737-A1 5-OXA-2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS Novartis AG (CH) 2022-08-17 EP disclosed
WO-2021070091-A1 5-OXA-2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS NOVARTIS AG (CH) 2021-04-15 WO disclosed
WO-2021070090-A1 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS NOVARTIS AG (CH) 2021-04-15 WO disclosed